AFP and hepatocellular carcinoma: In our current study, AFP in HBV‐HCC patients receiving antiviral treatment was significantly lower than that in the no‐antiviral group, despite the observation that antiviral therapy did not alter serum AFP of CHB patients, suggesting that antiviral therapy will not be able to abolish completely the incidence of HBV‐HCC.